Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.
复制标题
双互补位抗体 BA7208/7125 有效中和 SARS-CoV-2 变体,包括 Omicron BA.1-BA.5
DOI:
10.1038/s41421-022-00509-9
复制
发表时间:
2023-01-07
期刊:
影响因子:
33.5
通讯作者:
Zhao, Jincun
中科院分区:
文献类型:
--
作者:
Wang, Yanqun;Yan, An;Song, Deyong;Dong, Chuangchuang;Rao, Muding;Gao, Yuanzhu;Qi, Ruxi;Ma, Xiaomin;Wang, Qiaoping;Xu, Hongguang;Liu, Hong;Han, Jing;Duan, Maoqin;Liu, Shuo;Yu, Xiaoping;Zong, Mengqi;Feng, Jianxia;Jiao, Jie;Zhang, Huimin;Li, Min;Yu, Beibei;Wang, Yanxia;Meng, Fanhao;Ni, Xiaodan;Li, Ying;Shen, Zhenduo;Sun, Baiping;Shao, Xin;Zhao, Haifeng;Zhao, Yanyan;Li, Rui;Zhang, Yanan;Du, Guangying;Lu, Jun;You, Chunna;Jiang, Hua;Zhang, Lu;Wang, Lan;Dou, Changlin;Liu, Zheng;Zhao, Jincun
SARS-CoV-2 Omicron subvariants have demonstrated extensive evasion from monoclonal antibodies (mAbs) developed for clinical use, which raises an urgent need to develop new broad-spectrum mAbs. Here, we report the isolation and analysis of two anti-RBD neutralizing antibodies BA7208 and BA7125 from mice engineered to produce human antibodies. While BA7125 showed broadly neutralizing activity against all variants except the Omicron sublineages, BA7208 was potently neutralizing against all tested SARS-CoV-2 variants (including Omicron BA.1–BA.5) except Mu. By combining BA7208 and BA7125 through the knobs-into-holes technology, we generated a biparatopic antibody BA7208/7125 that was able to neutralize all tested circulating SARS-CoV-2 variants. Cryo-electron microscopy structure of these broad-spectrum antibodies in complex with trimeric Delta and Omicron spike indicated that the contact residues are highly conserved and had minimal interactions with mutational residues in RBD of current variants. In addition, we showed that administration of BA7208/7125 via the intraperitoneal, intranasal, or aerosol inhalation route showed potent therapeutic efficacy against Omicron BA.1 and BA.2 in hACE2-transgenic and wild-type mice and, separately, effective prophylaxis. BA7208/7125 thus has the potential to be an effective candidate as an intervention against COVID-19.
登录
查看更多内容
影响因子:
64.8
作者:
Barnes CO;Jette CA;Abernathy ME;Dam KA;Esswein SR;Gristick HB;Malyutin AG;Sharaf NG;Huey-Tubman KE;Lee YE;Robbiani DF;Nussenzweig MC;West AP Jr;Bjorkman PJ
通讯作者:
Bjorkman PJ
影响因子:
64.5
作者:
Li C;Zhan W;Yang Z;Tu C;Hu G;Zhang X;Song W;Du S;Zhu Y;Huang K;Kong Y;Zhang M;Mao Q;Gu X;Zhang Y;Xie Y;Deng Q;Song Y;Chen Z;Lu L;Jiang S;Wu Y;Sun L;Ying T
通讯作者:
Ying T
影响因子:
64.5
作者:
Hoffmann M;Arora P;Groß R;Seidel A;Hörnich BF;Hahn AS;Krüger N;Graichen L;Hofmann-Winkler H;Kempf A;Winkler MS;Schulz S;Jäck HM;Jahrsdörfer B;Schrezenmeier H;Müller M;Kleger A;Münch J;Pöhlmann S
通讯作者:
Pöhlmann S
影响因子:
17.1
作者:
Jones BE;Brown-Augsburger PL;Corbett KS;Westendorf K;Davies J;Cujec TP;Wiethoff CM;Blackbourne JL;Heinz BA;Foster D;Higgs RE;Balasubramaniam D;Wang L;Zhang Y;Yang ES;Bidshahri R;Kraft L;Hwang Y;Žentelis S;Jepson KR;Goya R;Smith MA;Collins DW;Hinshaw SJ;Tycho SA;Pellacani D;Xiang P;Muthuraman K;Sobhanifar S;Piper MH;Triana FJ;Hendle J;Pustilnik A;Adams AC;Berens SJ;Baric RS;Martinez DR;Cross RW;Geisbert TW;Borisevich V;Abiona O;Belli HM;de Vries M;Mohamed A;Dittmann M;Samanovic MI;Mulligan MJ;Goldsmith JA;Hsieh CL;Johnson NV;Wrapp D;McLellan JS;Barnhart BC;Graham BS;Mascola JR;Hansen CL;Falconer E
通讯作者:
Falconer E
DOI:
10.3390/v14020294
发表时间:
2022-01-30
期刊:
Viruses
影响因子:
--
作者:
Grabowski F;Kochańczyk M;Lipniacki T
通讯作者:
Lipniacki T